Paula Munderi

Joint United Nations Programme on HIV/AIDS — Switzerland

Medicine · Health Sciences

32h-index4.1kcitations144works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS Research and Interventions(88), HIV Research and Treatment(64), HIV/AIDS drug development and treatment(59), HIV-related health complications and treatments(23), Pneumocystis jirovecii pneumonia detection and treatment(19)

Publications139 total

Interventions to improve men’s engagement in HIV and other key services in sub-Saharan Africa: a scoping review
2023· 3 citedOpen Access
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
BMC Pregnancy and Childbirth·2023· 2 citedOpen Access
Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions
Virus Evolution·2021· 7 citedOpen Access
The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa
AIDS·2021· 12 citedOpen Access
Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda
Journal of Antimicrobial Chemotherapy·2019· 21 citedOpen Access
Dyslipidemias and cardiovascular risk scores in urban and rural populations in north-western Tanzania and southern Uganda
PLoS ONE·2019· 11 citedOpen Access
Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min
PLoS ONE·2019· 3 citedOpen Access
Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus–Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy
The Journal of Infectious Diseases·2019· 9 citedOpen Access
Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda
HIV Medicine·2019· 21 citedOpen Access
Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV
Southern African Journal of HIV Medicine·2019· 5 citedOpen Access
Investing in Development A Practical Plan to Achieve the Millennium Development Goals
2019· 303 cited
Prevalence of high blood pressure and associated factors among adolescents and young people in Tanzania and Uganda
Journal of Clinical Hypertension·2019· 47 citedOpen Access
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial
PLoS ONE·2018· 23 citedOpen Access
Expert consensus statement on the science of <scp>HIV</scp> in the context of criminal law
Journal of the International AIDS Society·2018· 110 citedOpen Access
Efficacy and safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults stabilized on ART in Uganda: randomised controlled trial
London School of Hygiene & Tropical Medicine·2018Open Access
Viable dual therapy second-line antiretroviral regimen for Africa?
The Lancet HIV·2017
COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort
AIDS Research and Therapy·2017· 21 citedOpen Access
Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations
Digital Access to Scholarship at Harvard (DASH) (Harvard University)·2017Open Access
Hepatitis B serological markers and plasma DNA concentrations
AIDS·2017· 17 citedOpen Access
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
BMC Infectious Diseases·2017· 4 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Heiner Grosskurth(21), Charles F. Gilks(20), Diana M. Gibb(18), Francis Ssali(14), Cissy Kityo(13), A. Sarah Walker(12), Peter Mugyenyi(12), Pontiano Kaleebu(12), Andrew Reid(9), James Hakim(8), Elly Katabira(7), A. Medina Lara(7), Kusum Nathoo(6), Ronnie Kasirye(5), Fred Lyagoba(5), Jonathan Levin(5), James Hakim(5), Victor Musiime(5), Andrew J. Prendergast(5), Christine Watera(5)